The table below shows Bluejay Diagnostics, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$1.59M
-$1.18M
-$2.30M
-$2.93M
-$1.88M
-$372.62K
Capital expenditure
$18.99K
-
$35.43K
$340.67K
$46.35K
-
Investing cash flow
-$15.31K
-
-$35.43K
-$340.67K
-$46.35K
-
Dividends paid
-
-
-
-
BJDX operating cash flow (10-K history)
Bluejay Diagnostics, Inc. reported operating cash flow of -$6.05M for fiscal year 2025. That is up 22.6% from -$7.82M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$508.71K (FY 2020) to -$6.05M. Figures come from the company's audited annual reports as filed with the SEC.